Inhibrx Biosciences, Inc. (INBX) earnings · rev $1.3M
These earnings events as JSON? API free 100/dayInhibrx Biosciences, Inc. (INBX) is a biotechnology company listed on US.
This INBX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported INBX revenue for 2025-12-31 was $1.3M. Net income was -$140.1M. Revenue was up 550.0% from 2024-12-31 to 2025-12-31. INBX currently screens at market cap $1.28B.
When the next INBX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 550.0% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full INBX research stays on the stock page; the tape stays on the quote page.
INBX earnings FAQ
What are INBX's latest revenue and net income?
Latest cached Inhibrx Biosciences, Inc. (INBX) revenue for Dec 31, 2025 was $1.3M. Net income was -$140.1M. Statements: https://lician.com/financials/inbx
What is INBX's latest diluted EPS?
Latest cached Inhibrx Biosciences, Inc. (INBX) diluted EPS for Dec 31, 2025 was -$9.04.
What period does the latest INBX earnings print cover?
The latest cached Inhibrx Biosciences, Inc. (INBX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did INBX revenue change from the prior cached period?
Cached Inhibrx Biosciences, Inc. (INBX) revenue was up 550.0% from $200.0K (Dec 31, 2024) to $1.3M (Dec 31, 2025). Statements: https://lician.com/financials/inbx
Where are INBX earnings listed?
Cached earnings facts for Inhibrx Biosciences, Inc. (INBX) are listed at https://lician.com/earnings/inbx. Statements: https://lician.com/financials/inbx
Not investment advice.